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Abstract Pregnant women who use drugs are more likely
to receive little or no prenatal care. This study sought to
understand how drug use and factors associated with drug
use influence women’s prenatal care use. A total of 20
semi-structured interviews and 2 focus groups were con-
ducted with a racially/ethnically diverse sample of low-
income women using alcohol and drugs in a California
county. Women using drugs attend and avoid prenatal care
for reasons not connected to their drug use: concern for the
health of their baby, social support, and extrinsic barriers
such as health insurance and transportation. Drug use itself
is a barrier for a few women. In addition to drug use,
women experience multiple simultaneous risk factors. Both
the drug use and the multiple simultaneous risk factors
make resolving extrinsic barriers more difficult. Women
also fear the effects of drug use on their baby’s health and
fear being reported to Child Protective Services, each of
which influence women’s prenatal care use. Increasing the
number of pregnant women who use drugs who receive
prenatal care requires systems-level rather than only indi-
vidual-level changes. These changes require a paradigm
shift to viewing drug use in context of the person and
society and acceptance of responsibility for unintended
consequences of public health bureaucratic procedures and
messages about effects of drug use during pregnancy.
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Introduction
Pregnant women who use drugs are over-represented
among women who receive late, limited, and no prenatal
care [1–5]. Similar to pregnant women in general [6],
women who use drugs and receive adequate prenatal care
generally have better pregnancy outcomes than women
who use drugs and do not receive adequate care [7–16]. It
is unclear whether these improvements are due to prenatal
care or if lack of prenatal care is a proxy for other risk
factors associated with poor outcomes [13, 17]. Neverthe-
less, lack of prenatal care clearly limits opportunities for
offering other health promoting interventions.
The limited research suggests that women who use
drugs during pregnancy face the following barriers to
prenatal care: difficulties with transportation and health
insurance [18], ‘‘drug lifestyle’’ [19], fear of having drug
use identified by providers [20], and fear of legal reper-
cussions [21], including Child Protective Services (CPS)
reports [22]. In addition, a recent study examined whether
drug use itself or factors associated with drug use are
barriers [23]. The study found that both drug use and fac-
tors associated with drug use are barriers, although this
differs depending on the specific drug.
The existing research primarily tests researchers’ a pri-
ori hypotheses [24]. Thus, it may exclude some key bar-
riers. In addition, it has focused on determining the most
common barriers [18] and on determining which risk fac-
tors explain the most variance in limited prenatal care [23].
While each are important, they do not provide information
on how drug use or factors associated with drug use
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become barriers to prenatal care. With the goal of
informing interventions to reduce barriers to prenatal care
for women who use drugs during pregnancy, this qualita-
tive study identifies women’s perspectives on barriers to
prenatal care and seeks to understand the processes through
which drug use and factors associated with drug use during
pregnancy become barriers.
Methods
This exploratory qualitative research was conducted
between September and December 2006 in a northern
California county. The county has a population of just over
one million people, and is diverse in terms of race/eth-
nicity, income, and rural/urban status. Goals were to
identify barriers to prenatal care and factors that encourage
use of prenatal care by pregnant women who use alcohol
and/or drugs and engage women in identifying strategies to
reduce barriers. Human Subjects approval was obtained
from University of California, Berkeley and informed
consent was obtained from each participant.
Women with current alcohol and/or drug use or a history
of substance abuse who were pregnant or had a child
2 years old or younger were eligible and were recruited
from substance abuse treatment, a home-visiting program,
and the Women, Infants, and Children (WIC) Program.
Staff at these sites recruited women through a standardized
script and posted flyers. Women then self-identified to the
lead investigator (first author) either by phone or when she
was onsite at the agency/organization. The intention of this
purposive sampling strategy was to find pregnant women
and new mothers who were currently using alcohol and/or
drugs or had a history of alcohol and/or drug use during
pregnancy who could talk about challenges that pregnant
women who use alcohol and/or drugs face in entering and
continuing prenatal care. Despite our intention of including
women who used alcohol only, both alcohol and drugs, and
drugs only, our sample only includes women using drugs,
either alone or in combination with alcohol. It does not
include women using alcohol without drugs.
Thirty-eight women participated. Twenty semi-struc-
tured interviews [25] and two focus groups (with eight and
ten women each) were conducted. About one half of
interview participants (n = 11) and all focus group par-
ticipants were recruited from treatment. Interview and
focus group guides addressed: women’s thoughts about and
experiences with prenatal care; barriers and facilitators to
prenatal care for women who use alcohol and/or drugs; and
women’s thoughts about how the health department and
health care providers could encourage women who use
alcohol and drugs to enter prenatal care earlier, including
ideas for a community awareness campaign. Women were
also asked close-ended questions about demographics,
timing of entry to prenatal care, and type of substance
(alcohol and/or which drug) they used. Focus group par-
ticipants provided this information in exit surveys. Due to
an error with exit survey printing, women in focus groups
were not asked questions about timing of prenatal care
entry. The questions about alcohol and drug use were used
to classify participants as using alcohol only, alcohol and
drugs, or drugs only. Women were treated as study par-
ticipants, key informants, and collaborators in community
awareness campaign development. Women who were not
pregnant at study participation (74%) were asked about
their most recent pregnancy.
Interviews and focus groups lasted approximately 60
and 90 min, respectively and were recorded on audio-
cassette. Participants received $30 and $20 Target gift
cards for interviews and focus groups.
Interviews and focus groups were transcribed verbatim
and supplemented by notes. The transcriptions, combined
with women’s drawings of their ideas for the community
awareness campaign, served as the basis for the analysis.
Coding was completed in a multiphase, iterative pro-
cess. We had some general ideas of the barriers women
might report prior to initiating the study. However, we did
not have an a-priori coding scheme. Initial codes were
developed in an inductive process [26] based on the first
nine interview and both focus group transcripts. Codes
were then added and refined based on the remaining eleven
interviews. A codebook was created and then used to code
the entire set of interview and focus group transcripts.
Memos were used during coding to track ongoing analysis
insights and after coding was completed to explore dif-
ferent aspects of identified themes and determine the
number and quality of quotations supporting themes and
different aspects of themes [27].
Case-studies, a cross-case study, and typology were also
used [28]. Case studies of each interview participant were
created to document the timing of prenatal care entry in
relation to drug use cessation and factors that facilitated or
hindered prenatal care entry. A cross-case study using data
from all interview participants then categorized each
woman based on her trimester of prenatal care entry and
timing of drug use cessation. Health insurance status and
previous CPS involvement emerged as themes and were
added to the cross-case study. Timing of prenatal care
entry, timing of drug use cessation, and structural barriers
were then graphed to explore the relationships between
timing of each behavior and structural barriers. Fisher’s
exact tests were used to test (1) whether problems with
health insurance were associated with entry after first tri-
mester and (2) whether entering after first trimester and/or
having stopped use before entering were associated with
previous CPS involvement. The statistical significance of
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the second test differed depending on whether the
denominator was restricted to only those with at least one
child prior to the index pregnancy; however, the trend was
in the same direction for both. Findings from the full
sample are reported. Finally, women were categorized
based on how they responded to common fears, such as
fears of being reported to CPS. For example, a typology
[28] was created based on subthemes of similarities and
differences [24] in ways that women respond to their fears
of being reported to CPS in relation to prenatal care.
Validity checks included (1) respondent validation,
where initial findings were shared with other women sim-
ilar to initial participants, staff at agencies where partici-
pants were recruited, providers, and policymakers and
feedback requested; (2) field time of more than 3 years that
the lead investigator spent in the study setting; (3) use of
multiple methods of data collection (interviews and focus
groups) to triangulate findings relating to barriers to and
facilitators of prenatal care; and (4) checks of how sup-
ported a key finding relating to fear of CPS was both across
and within interviews [26, 27]. This final check was con-
ducted after coding was completed to ensure that our
finding was not driven by only one or two interviews.
Results
Sample Description
Participants were a racially and ethnically diverse sample
of 38 low-income English-speaking pregnant and parenting
women. About one-fourth (26%) were pregnant at the time
of study participation. Those who were not pregnant had a
child 2 years old or younger. Most had received some
prenatal care in their most recent pregnancy: 50% (n = 10)
of those participating in individual interviews entered in
their first trimester; 25% (n = 5) second trimester; and
20% (n = 4) third trimester. Five percent (n = 1) received
no prenatal care. Most women used more than one sub-
stance. Methamphetamine (61% n = 23) and crack/
cocaine (16% n = 6) were the most common primary
substances. Many used alcohol (42% n = 16), but none
reported an ‘‘alcohol only’’ pattern of use.
‘‘Same Reasons Somebody Who’s Not Using Goes’’
Women reported attending and avoiding prenatal care for
the ‘‘same reasons somebody who’s not using goes,’’ that
is, reasons not connected to their drug use. A main reason
they reported attending was ‘‘to make sure the baby’s ok.’’
Women reported going for checkups, information, answers
to questions, reassurance, prenatal vitamins, and to avoid
birth defects and other health problems.
[Prenatal care] affects a baby a lot. If, you’re having
any conditions or whatever, then [doctors] can, it
minimizes the chances of your child being born with
deficiencies.
With the doctor monitoring the baby and finding out
if it’s going to be a healthy baby, if everything’s
gonna be ok, if everything’s growing right, [if] all the
toes and fingers are there. That way they can detect
infant problems early on and maybe help that
situation.
Having health insurance, a belief in the utility of prenatal
care, and social support also facilitated prenatal care use.
Women also reported not attending prenatal care for
reasons unconnected to their drug use. These reasons
included extrinsic barriers, such as problems with trans-
portation, health insurance, and scheduling appointments,
and feeling that providers do not listen, take concerns
seriously, or spend enough time with them.
He wasn’t answering my questions, he was very
rushed. I’m trying to ask questions and he answered
them on his way out the door. Then when I switched
over to [new prenatal care site] I was voicin’ con-
cerns about my pregnancy and they were just pushed
off, not taken care of, pushed off. I wasn’t happy
about that.
Drug Use as Barrier
Drug use itself was also a barrier. A few women reported
prioritizing opportunities to use drugs and get high over
prenatal care.
Dope prevented me from going [to the doctor]...My
husband kept trying. He tried driving me, making
appointments for me, everything. I was just too doped
up to hear anything.
Drug Use and Extrinsic Barriers
Multiple Simultaneous Risk Factors
Women also faced extrinsic barriers: lack of transporta-
tion, health insurance, and financial barriers; homeless-
ness; and bureaucratic barriers relating to obtaining
insurance and scheduling appointments. Problems with
health insurance were common and predicted later entry
to prenatal care [See Fig. 1]. Some women attributed
these barriers to their drug use. Many women described
ways in which drug use interacted with and exacerbated
these barriers. Bureaucratic barriers were especially sig-
nificant for women who started to seek care later in
pregnancy.
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Women reported experiencing multiple extrinsic barri-
ers simultaneosly. Multiple simultaneous barriers seemed
to make resolving extrinsic barriers more difficult. For
example, obtaining health insurance was especially diffi-
cult for one homeless woman. She reported:
I had always intended on going and having prenatal
care, but the first blocker was the welfare department
and getting Medi-Cal...They had denied me Medi-Cal
because I was homeless [and therefore didn’t have an
address].
Some women saw drug use as related to and even as
causing some extrinsic barriers. For example, one woman
reported having been with a boyfriend in another town
using drugs and not having her own transportation to get to
prenatal appointments. Other women talked about how
drug use left them with few resources, which then made it
difficult to resolve the barriers. As one explained:
[My drug use made it hard for me to get an]
appointment because by the time I found out I was
pregnant, I had zero dollars, zero friends, a car that I
couldn’t drive, I didn’t have internet, I didn’t have
telephone, and finding services to get the ball rolling
in that way. Then in the phone book it doesn’t exist.
So if you don’t have internet access, you’re kind of in
the dark.
Resolving bureaucratic barriers took persistence and
determination. Drug use made resolving bureaucratic
barriers more difficult because of both competing priorities
and system gaps. Drug use itself, the stress of reducing or
managing drug use, and the stress of leaving abusive
partners with whom women used drugs were factors that
women described as making it difficult to prioritize
resolving bureaucratic barriers.
I didn’t have Medi-Cal. I was very confused about
how to go get emergency Medi-Cal, how it would
only last for like 90 days and then how I’d have to
go back and re-apply and then have to wait for that
to come through, and how to find a doctor. It took
me the longest time to try and see a doctor. My
sister, she got pregnant and she sees own her pri-
vate doctor, she also has Medi-Cal. It’s just like,
why is it so easy for her and like the world coming
down on and I don’t know what to do...People were
telling me you need to see a doctor, but you need to
wait for all these things to come through, and it
was just stressful. Especially for someone who’s
coming off drugs and trying to do what they’re
supposed to. Even just getting through 1 day is
stressful.
[I had gotten pregnant] through a sexual abuse with
my ex [who introduced me to meth], so part of me
shut down emotionally and didn’t want to even
accept that I [was] pregnant...[so], prenatal care
wasn’t high on my list, [figuring out how to get
insurance] kind of just got pushed to the side because
of my emotional issues, trying to deal with how I was
going to leave him.
Some women also reported having unique concerns or
situations related to their drug use that conflict with
bureaucratic procedures. For example, a few women
mentioned drug-related paranoia. One woman explained
how this paranoia made it difficult to complete forms in
public places.
You can’t fill out Medi-Cal forms and everything if
you’re paranoid. You’re afraid everybody’s looking
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Fig. 1 Trimester of prenatal
care entry and insurance
problems among interview
participants (n = 20)
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Other women mentioned delays in discovering pregnancy.
Some saw these delays as due, in part, to drug use. These
delays led to them to begin obtaining insurance and
scheduling appointments later in pregnancy. Starting these
processes later created additional barriers, especially with
scheduling appointments.
I didn’t know where to go, my boyfriend just drove
me to [county clinic] to make an appointment. We
just waited in that line at the information window 12
over there, the information booth, went up to the
window and said I’m pregnant. The woman said, how
far along are you? I hadn’t seen a doctor at that point
so I had no clue. So, she said, let me see your
stomach. And she said, oh you can’t be more than 3
or 4 months pregnant. But it turned out that I was 6
or 7 months pregnant at that time. Wow. So really I
should have been seen at that time. ‘Cause I went on
her word, I waited to figure out where to go.
I started with the doctor she referred me to, took him
a week to call me back, and then he told me he
couldn’t take me because I was past 7 months along,
and he didn’t take patients that far along.
Drug Use and Social Support
Drug use during pregnancy also interacted with women’s
ability to resolve extrinsic barriers by influencing access to
social networks. Informational and tangible support from
familial and drug-using networks helped women resolve
extrinsic barriers. For example, informational support from
these networks helped some women obtain insurance.
The lady across the street [from my parents], actually,
our neighbor, who was the administrator at [local
hospital], she, at one point, probably was the one that
told my mom, look at Medi-Cal.
It was the first couple of days I was [at the treatment
program] and there was a pregnant girl there that told
me ‘cause I had been tryin’ to get the Medi-Cal
straightened out.
Partners sometimes helped resolve extrinsic barriers.
My boyfriend kind of went the extra mile for me. He
helped me get out of bed, made me go even when I didn’t
want to go stand on long lines just to get turned down,
[helped] when we needed to sell our stuff so we could get
gas money so we could go [to the] county [office].
In contrast, some women reported that their drug use isolated
them from their families and other non-users. Some took steps
to hide drug use and pregnancy from family and non-using
partners, making it difficult to obtain support.
[My family] didn’t even know I was pregnant. I did
hide for about 7 months because I didn’t show very
well till about 7 months. I was trying to hide it any-
ways, ‘cause that first step, admitting you’re pregnant
with the person they hated and despised and knew he
was a druggie and causing problems with me.
Other women reported that when they reduced or stopped
drug use, they lost access to drug-using friends and partners
who wanted them to continue to use drugs with them.
Conversely, a few also reported exclusion from drug-using
networks due to pregnancy.
People don’t give you drugs when you’re pregnant.
Exclusion from these networks made it more difficult to
obtain informational support to resolve extrinsic barriers.
Drug Use and Desire for Healthy Baby
Many women feared that their drug use had already harmed
or would harm their baby. Some women felt guilty about
their use because of this fear.
That guilt of knowing that you’ve used, ‘cause you
know 9 times out of 10 [it] will affect your baby in
some way form or another.
Some addressed their guilt and concerns by attending
prenatal care. Of women who attended, some reported
doing so to compensate for the effects of drug use.
[I’m glad that I went to the doctor during my preg-
nancy] because I was able to see that my child was
growing healthy and that I was doing all the right
things as far as my diet and making sure that I ate lots
of folic acid and stuff at the same time I was using.
A key component of compensating was obtaining prenatal
vitamin prescriptions, which many women saw as having
important health benefits. A few saw taking vitamins as
helping compensate for drug use.
The baby has got to be healthy. I mean I need the
prenatal pills. They[‘re] for the baby. I knew I wasn’t
eatin’ right. I wanted to get as much nutrition, vita-
mins, minerals and everything that the baby needed
as possible. So I made sure that I went to the doctor,
and took my pills and ate as healthy as possible.
Some women also attended because they believed the
doctor might discover and therefore minimize problems
associated with drug use.
It’s extremely important [to attend prenatal care]
especially in the fact that you use drugs because if
you let your provider know, they can make sure to
check for...difficulties or problems that might arise
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from your use and you can minimize a lot of damage
that way.
Other women attended to get reassurance that their baby
was healthy. This reassurance helped relieve stress and
anxiety.
I was so worried because I had used in the first couple of
months that...there was going to be something wrong
with my baby. Being able to go to prenatal care took a lot
of that stress off me, ‘cause they’re telling me my baby’s
ok and I’m not this and I’m not that. That relieved a lot of
stress on my part, a lot of stress.
Simply attending prenatal care also relieved guilt for some
women by helping them feel they were doing something
right. This feeling that they were doing something right, in
turn, helped them feel good about themselves.
However, the guilt about effects of drug use sometimes
kept women away from prenatal care. Some avoided pre-
natal care out of fear they would learn they had already
harmed their baby.
The more clean I got, I was like out of there, I was
like tripping, like hella trippin’...I d[id]n’t know
what’s going on with my kid. The guilt was really
bad. I was scared, I didn’t want to know. I really
didn’t, I did not want to know if there was anything
wrong.
Learning from the doctor they had harmed their baby by
using drugs would have increased guilt. Others tried to deal
with the guilt on their own. Some tried to reduce or stop
their use. Others continued drug use to escape from guilt.
Each led to delays in prenatal care entry.
The drugs lie to you in your brain, they tell you
everything’s gonna be ok, to don’t worry about it, just
smoke me, smoke me. But at the same time, you’re
knowing deep down in the back of the mind, espe-
cially when you’re coming down off the shit, you
know what I mean?...When you’re coming down off
of it, that’s when you’re feeling guilty about it, that’s
when you really start to feel guilty and that’s when
you regret. Until you get that next hit of course.
When women used drugs to calm their guilt, this use
sometimes increased guilt. Women reported that both the
drug use and the increased guilt from the drug use then
made it more difficult to attend prenatal care.
Drug Use and Fear of CPS
Finally, most women feared that attending prenatal care
while using drugs would lead to CPS reports and losing
their children.
When you’re using and you think about prenatal care,
you’re nervous and you’re scared because you don’t
want anybody to take your baby. That’s the first thing
on your mind.
Most women avoided prenatal care or attempted to stop
using drugs before attending prenatal care because of fear
of CPS [See Fig. 2].
I didn’t [go while] I was using because I was afraid
that, if they had known, that CPS would have been
involved, that Social Services would have taken my
baby.
That whole time, that whole 9 months, you’re like, I
cannot go to this doctor because if I do, they’re gonna
take my kid or put [me] in jail for the rest of [my]
9 months just to take the baby when [I deliver].
A few attended in spite of fear of CPS because they
prioritized their baby’s health. One woman who used
methamphetamine and marijuana throughout her preg-
nancy explained:
[Fear of CPS] made me not want to go, but because I
was high risk, there was a greater chance of, I care
more about my son being ok...so, I never missed a[n]
appointment.
Others attended because of fear of CPS. They saw prenatal
care as increasing their chances of keeping the baby with
which they were currently pregnant and reunifying with
children who had been removed.
One of the reasons I went was because I didn’t want
them to take the baby away.
Discussion
Participants reported similar barriers to prenatal care as
low-income women in general [29–31]. In addition, both
drug use and factors associated with drug use influence
prenatal care use. Drug use itself is a reason a few women
do not attend prenatal care. However, for most women,
drug use became a barrier to prenatal care by interacting
with additional individual, interpersonal, systems, and
policy-level factors. First, as has been found previously,
pregnant women who use drugs face multiple barri-
ers [32, 33]. Experiencing multiple barriers simultaneously
makes resolving each barrier more difficult. They also may
be especially at risk for certain bureaucratic barriers, such
as finding doctors willing to start seeing women during
their third trimester. Second, women believe that drug use
during pregnancy is very harmful to the fetus. While a
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motivator to attend prenatal care for some women, this
belief appears to scare other women to the point that they
delay entering prenatal care. Women’s beliefs are consis-
tent with some public health messages about effects of drug
use during pregnancy [34–36]. It is important to note that
recent research suggests that drug use during pregnancy
may not be as harmful as women believe and public health
messages suggest [37, 38]. Third, women report isolation
from potentially supportive networks due to their drug use
during pregnancy. These same messages may stigmatize
women who use drugs during pregnancy. This stigma
appears to isolate women from social networks that could
facilitate prenatal care use. Finally, as suggested by ACOG
and found by other qualitative, but not quantitative
research [18, 22, 23, 39], fear of CPS reports is a common
and significant barrier. Fear of CPS reports may be war-
ranted based on current policy and practice [40–42]. While
drug use itself is a factor for some women, it does not
appear that late or limited prenatal care among women who
use drugs is caused solely by drug use itself. Rather, late or
limited prenatal care may be better understood as one
rational response to public health messages and CPS
reporting practices, and as an indicator of systems-gaps.
These findings should be interpreted in light of the
study’s limitations. First, the sample is a small non-repre-
sentative sample of agency-involved women in one county.
Second, few participants were using drugs at the time of
participation and many were or had been involved with
CPS, each of which may have influenced what they chose
to focus on during interviews and focus groups. Third, the
assessment of alcohol and drug use only included questions
about type of substance and did not include quantity/fre-
quency questions or questions about problem severity,
which limits generalizability. However, the questions
asked suggest that findings apply to women who use
methamphetamine or cocaine, either alone or in combina-
tion with marijuana, alcohol, and other drugs; and may not
generalize to women using opiates or using marijuana only,
because they were not represented in the sample. However,
more research with better alcohol/drug measures is needed
to confirm these findings and to determine whether women
with more or less frequent use or more or less severe
problems experience the same barriers. Fourth, other
counties may respond differently to drug use during preg-
nancy and may have different systems, such as easier third-
trimester entry to care or services to assist homeless
women obtain insurance. Finally, the direction of causality
between drug use and extrinsic barriers is not possible to
determine. While some participants spoke of their drug use
as causing the barriers, it is possible that any association
between the two is not a simple uni-directional causal
relationship [43] and that each indicate higher risks from
more distal factors [44].
This study also has strengths. Findings are largely
consistent with prior research on barriers to prenatal care
for pregnant women who use drugs [18, 19, 22, 23].
However, this research also extends previous research by
(1) identifying new barriers that have not been previously
documented—fear of the effects of drug use and isolation
from social networks; (2) finding additional support that
fear of CPS is a barrier; (3) identifying how drug use
becomes a barrier; and (4) regardless of the direction of
causality, describing ways in which multiple simultaneous
barriers make it more difficult to resolve barriers. This
study also extends previous research by identifying sys-
tems-level barriers, including those related to public health
bureaucratic procedures, messages, and CPS reporting
policies/practices, rather than solely focusing on individ-
ual-level risk factors.
Conclusions
Findings suggest that reducing the number of pregnant
women who use alcohol and drugs who receive late or
limited prenatal care requires more than telling women to
stop drug use. It requires acknowledging the complexity of
women’s decision-making about prenatal care, the diver-
sity among women who use drugs during pregnancy, and a















Entered 1st trimester or while using drugs
Entered after 1st trimester or stopped using drugs before entry
Fig. 2 Timing of prenatal care
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change. Some interventions that may increase prenatal care
utilization are: (1) new messages about the effects of drug
use during pregnancy that identify steps that pregnant
women who have already used drugs can take to increase
chances of having healthy babies; (2) clarified CPS
reporting policies; (3) streamlined insurance applications;
and (4) easier access to providers who accept women in
their third trimesters. Addressing these systems-level bar-
riers as opposed to focusing on drug use as an isolated and
silver-bullet risk factor will require a paradigm shift to
viewing drug use and prenatal care utilization in the con-
text of multiple interacting risk factors and social envi-
ronment [33, 45, 46]. It will also require increased
recognition that public health messages and bureaucratic
procedures can create barriers and acceptance of respon-
sibility for unintended [47] and potentially iatrogenic [48]
consequences of these messages and procedures.
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